News

Find News

Filter articles

Showing 1 to 10 of 2879 results

Amarin suffers defeat over Vascepa patents

US01-04-2020Sarah Morgan

A US judge has opened the door to generic versions of heart disease drug Vascepa, after invalidating Amarin’s key patents covering the drug. 

Gilead expands special access to potential COVID-19 drug

US31-03-2020Rory O'Neill

Gilead Sciences says it is expanding access to its experimental antiviral remdesivir for treatment of COVID-19, albeit on a limited basis.

Associations lobby WHO to build COVID-19 IP pool

Costa Rica31-03-2020

Numerous associations and individuals have come together to ask the World Health Organization to build a global pool for IP rights related to the COVID-19 pandemic.

Canada authorises compulsory licences for COVID-19 shortfalls

Canada27-03-2020Rory O'Neill

Canada is the latest country to adopt emergency measures in order to secure drugs and medical equipment in the fight against COVID-19.

Novartis and others in ‘unprecedented’ COVID-19 partnership

China, UK, US27-03-2020

A consortium of life sciences companies including Novartis, Bristol Myers Squibb and GSK have united to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19. 

Gilead backs away from antiviral monopoly after criticism

US26-03-2020Rory O'Neill

Gilead Sciences has agreed to drop the lucrative “orphan drug” designation for an antiviral touted as a potential coronavirus treatment, after criticism from activists and politicians including Bernie Sanders.

Abbott scores case-ending sanctions against wholesaler

US26-03-2020Sarah Morgan

Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.

Webinar: Plenty to fight for in CRISPR IP battle

US26-03-2020

Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

Costa Rica asks WHO to create voluntary COVID-19 IP pool

Costa Rica26-03-2020

The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

US companies hit hardest by fake medicines: EUIPO, OECD

EU24-03-2020Sarah Morgan

Companies registered in the US are hit hardest by the trade in counterfeit medicines, which in 2016 reached $4.4 billion, according to a report from the European Union Intellectual Property Office. 

Showing 1 to 10 of 2879 results

LSIPR